The D Company develops, manufactures, distributes, and markets branded health care
products as well as private-label vitamin products in the United States and more than 50
other countries. A disclosure note from D’s 2014 annual report is shown below:
Weighted Average Shares Outstanding
The following table provides information about basic and diluted weighted average
shares outstanding:
The computations of diluted weighted average shares outstanding exclude 4 million
shares in fiscal year 2016, 2 million shares in fiscal year 2015 and 1 million shares in
fiscal year 2014 since the options were antidilutive.
Required:
1) The disclosure note shows adjustments for “assumed exercise of stock options and
assumed vesting of restricted stock.” What other adjustments might be needed? Explain
why and how these adjustments are made to the weighted-average shares outstanding.
2) The disclosure note indicates that the effect of some of the stock options were not
included because they would be antidilutive. What does that mean? Why not include
antidilutive securities?